USANA Health Sciences, Inc (USNA) has reported 4.22 percent fall in profit for the quarter ended Apr. 01, 2017. The company has earned $21.36 million, or $0.86 a share in the quarter, compared with $22.30 million, or $0.89 a share for the same period last year.

Revenue during the quarter grew 6.19 percent to $255.32 million from $240.45 million in the previous year period. Gross margin for the quarter expanded 114 basis points over the previous year period to 83.29 percent. Total expenses were 87.12 percent of quarterly revenues, up from 86.07 percent for the same period last year. That has resulted in a contraction of 105 basis points in operating margin to 12.88 percent.

Operating income for the quarter was $32.89 million, compared with $33.50 million in the previous year period.

“USANA generated solid top-line and customer growth during the quarter,” said Kevin Guest, Chief Executive Officer. “Our earnings were impacted by additional expense related to our previously disclosed internal investigation during the quarter. Setting aside these expenses, our bottom-line results were essentially in-line with our expectations. We remain focused on implementing our 2017 growth strategies, including our initiatives designed to drive overall customer growth and our new product announcements later this year.”

For fiscal year 2017, USANA Health Sciences, Inc expects revenue to be in the range of $1,040 million to $1,070 million ans its diluted earnings per share to be in the range of $3.80 to $4.10.

Days inventory outstanding has decreased to 74 days for the quarter compared with 139 days for the previous year period. At the same time, days payable outstanding was almost stable at 20 days for the quarter, when compared with the previous year period.